Ignite Creation Date:
2024-05-06 @ 7:40 PM
Last Modification Date:
2024-10-26 @ 3:11 PM
Study NCT ID:
NCT06099314
Status:
RECRUITING
Last Update Posted:
2023-10-25
First Post:
2023-10-17
Brief Title:
Fruquintinib in the Cross-line Treatment of Refractory mCRC
Sponsor:
Wuhan Union Hospital China
Organization:
Wuhan Union Hospital China
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Fruquintinib |
| Metastatic Colorectal Cancer |
Keywords: